Within-center correlation in dialysis adequacy^☆

References 

1. United States Renal Data System: USRDS 1997 Annual Data Report. National Institutes of Diabetes and Digestive and Kidney Diseases. Bethesda, Maryland 1997.
2. Held PJ, Brunner F, Odaka M, Garcia JF, Port FK, Gaylin DS. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Amer J Kid Disease. 1990;15:451–457
3. United States Renal Data System: USRDS 1993 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, 1993.
4. Hakim RM, Buyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Amer J Kid Disease. 1994;23:661–669
5. Parker TM, Musni L, Huang W, Lew N, Laune EG, Dallas Nephrology Associates . Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Amer J Kid Disease. 1994;23:670–680
6. Owens WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J of Med. 1993;29:1001–1006
7. Held PJ, Port FK, Wolfe RA, Stannard DC, Canal CE, Daugirda JT, et al.  The dose of hemodialysis and patient mortality. Kidney Int. 1996;50:550–556
   • MEDLINE
   • CrossRef
8. Held PJ, Blagg C, Liska D, Hakim R, Levin N. The dose of hemodialysis according to dialysis prescription in Europe and the United States. Kidney Int. 1992;38(suppl.):S16–S21
9. McClellan WM, Frederick PR, Helgerson SD, Hayes RP, Ballard DJ, McMullen M. Data-driven approach to improving care of in-center hemodialysis patients. Health Care Fin Rev. 1995;16:129–140
10. Helgerson SD, McClellan WM, Frederick PR, Beaver SK, Frankfield DL, McMullen M. Improvement in adequacy of delivered dialysis for adult in-center hemodialysis patients in the United States. Amer J Kid Disease. 1997;29:851–861
11. Simpson JM, Klar N, Donner A. Accounting for cluster randomization (a review of primary prevention trials). Am J Pub Health. 1995;85:1378–1382
12. Donner A, Brown KS, Brasher P. A methodological review of non-therapeutic trials employing cluster randomization, 1979–1989. Int J Epidemiology. 1990;19:795–800
13. Donner A, Klar N. Statistical considerations in the design and analysis of community intervention trials. J Clin Epidemiol. 1996;49:435–439
    • Abstract
    • Full-Text PDF (581 KB)
    • CrossRef
14. Donner A, Klar N. Cluster randomization trials in epidemiology (theory and application). J Stat Plan Inf. 1994;42:37–56
15. Murray DM, Rooney FL, Hannan PJ, Getz JG, Marek PM, Orlandi M, et al.  Intraclass correlation among common measures of adolescent smoking (Estimates, correlates, and applications in smoking prevention studies). Am J Epidemiology. 1994;140:1038–1050
16. Snedecor GW, Cochran WG. Statistical Methods. 7th Ed. Ames: Iowa State University; 1981;
17. Fink JC, Armistead A, Turner M, Gardner J, Light P, for Mid-Atlantic Renal Coalition . Hemodialysis adequacy in Network 5 (Disparity between states and the role of center effects). Amer J Kid Disease. 1999;33(1):97–140
18. Mid-Atlantic Renal Coalition. Adequacy of Dialysis in Network 5. HCFA Contract No. 500-97-E023, July 1997.
19. Searle SR. Linear Models. New York: John Wiley; 1971;
20. Searle SR, Casella G, McCullock CE. Variance Components. New York: John Wiley; 1992;
21. Laird NM, Wave JH. Random effects models for longitudinal data. Biometrics. 1982;38:963–974
    • MEDLINE
    • CrossRef
22. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute; 1996;
23. NKF-DOQI Clinical Practice Guidelines for Dialysis Adequacy. New York: National Kidney Foundation, 1997.
24. Renal Physicians Association . Clinical Practice Guideline (Adequacy of Hemodialysis). Washington, DC: Renal Physician Association; 1993;
25. Glover JA. The incidence of tonsillectomy in school children. Proc R Soc Med. 1938;31:125–135
26. Chassin MR, Brook RH, Park RE, Keesey J, Fink A, Kosecoff J, et al.  Variations in the use of medical and surgical services by the medicare population. N Engl J Med. 1986;314:285–290
    • MEDLINE
    • CrossRef
27. Hirth RA, Turenne MN, Woods JD, Young EW, Port FK, Pauly MV, et al.  Predictors of type of vascular access in hemodialysis patients. JAMA. 1996;276:1303–1307
    • MEDLINE
28. Bender FH, Holley JL. Most nephrologists are primary care providers for chronic dialysis patients (Results of national survey). Amer J Kid Disease. 1996;28:67–71
29. Jones KR. Variations in the hemodialysis treatment process. Clinical Nursing Research. 1992;1:50–66
    • MEDLINE
    • CrossRef
30. Griffiths RI, Powe NR, Gaskin DJ, Anderson GF, de Lissovoy GVV, Whelton PK. The production of dialysis by for-profit versus not-for-profit freestanding dialysis facilities. Health Serv Res. 1994;29:473–486
    • MEDLINE
31. McClellan WM, Caruana R, Kishner J. Factors associated with center to center variation in the adequacy of hemodialysis. (Abstract) J Am Soc Nephrol 1995;6:550.
32. McClellan WM, Soucie JM. Facility mortality rates for new end-stage renal disease patients (implications for quality improvement). Amer J Kid Disease. 1994;24:280–289
33. Wolfe RA. The standardization mortality ratio revisited (Improvements, innovation, limitations). Amer J Kid Disease. 1994;24:290–292